Nadia Cocero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nadia Cocero has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Stefano Carossa
Department Head, Department of Surgical Sciences of the Dental School of the University of Torino, Turin, Italy
4 shared publicationsLaura Bergamasco
Oral Surgery Unit, Dental School, Joint Hospital-University Institution "Città della Salute e della Scienza", Turin, Italy
3 shared publicationsMarco Mozzati
SIOM Oral Surgery and Implantology Centre, Turin, Italy
3 shared publicationsBerardino Pollio
Centre for Inherited Bleeding and Thrombotic Disorders, Transfusion Unit, Joint Hospital-University Institution "Città della Salute e della Scienza", Turin, Italy
1 shared publicationCaterina Frascolino
Trainee, Oral Surgery Section, Dental School, University of Torino, Azienda Ospedaliera Città della Salute e della Scienza di Torino, Turin, Italy
1 shared publicationEleonora Caratori
Resident, Oral Surgery Section of the Dental School of the University of Torino at the Azienda Ospedaliera Città della Salute e della Scienza of Torino, Turin, Italy
1 shared publication
Latest Publications
- 1 February 2021
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 79 (2) , 305-312
Can Plasma Rich in Growth Factors Expedite Healing of Postextraction Tooth Sockets in Patients Undergoing Urgent Liver Transplantation?
- 1 February 2021
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 79 (2) , 305-312
Can Plasma Rich in Growth Factors Expedite Healing of Postextraction Tooth Sockets in Patients Undergoing Urgent Liver Transplantation?
- 1 August 2019
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 77 (8) , 1557-1565
Is It Safe to Remove Teeth in Liver Transplant Patients Without Antibiotics? A Retrospective Study of 346 Patients
- 1 August 2019
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 77 (8) , 1557-1565
Is It Safe to Remove Teeth in Liver Transplant Patients Without Antibiotics? A Retrospective Study of 346 Patients
- 1 March 2019
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 77 (3) , 463-470
Direct Oral Anticoagulants and Medical Comorbidities in Patients Needing Dental Extractions: Management of the Risk of Bleeding
- 1 March 2019
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 77 (3) , 463-470
Direct Oral Anticoagulants and Medical Comorbidities in Patients Needing Dental Extractions: Management of the Risk of Bleeding
- 1 January 2015
- Vol. 13 (2) , 287-294
Autologous plasma rich in growth factors in the prevention of severe bleeding after teeth extractions in patients with bleeding disorders: a controlled comparison with fibrin glue
Dental extractions in haemophiliacs may cause secondary bleeding, requiring repeated surgical and haematological interventions. As a local haemostatic, fibrin glue has recognised efficacy but, as a plasma-derived product, it carries the risk of viral infections. We, therefore, compared fibrin glue with an autologous haemostatic, plasma rich in growth factors (PRGF), in a controlled trial.One hundred and twenty patients with different blood disorders were randomised into two cohorts to undergo dental extraction procedures without hospitalisation. Prior to the extractions, patients underwent systemic haematological treatment. Complications were defined as secondary bleeding after the 7-day follow-up period or protracting after the repair procedure.There were 106 extractions (7 retained 3(rd) molars) in the group managed with fibrin glue: secondary bleeding affected 3/60 patients (5%) on the third day after extraction and necessitated additional surgery and systemic treatment (in one case the procedure had to be repeated on the 7(th) day). In the PRGF arm there were 98 extractions (23 retained 3(rd) molars): secondary bleeding affected two patients (3.3%) on the first day after extraction and was arrested with surgery without systemic treatment. Four out of the five secondary bleeds occurred in patients with haemophilia A. Concomitant diabetes or liver disease significantly increased the bleeding risk.The bleeding rates in the study and control arm prove that PRGF works as well as fibrin glue as a local haemostatic. Further assets are that PRGF has autologous origin, does not require additional systemic treatment in post-extraction repair surgery, is associated with an earlier onset of neo-angiogenesis and, overall, can reduce patients' distress and costs to the health system.
- 1 January 2015
- Vol. 13 (2) , 287-294
Autologous plasma rich in growth factors in the prevention of severe bleeding after teeth extractions in patients with bleeding disorders: a controlled comparison with fibrin glue
Dental extractions in haemophiliacs may cause secondary bleeding, requiring repeated surgical and haematological interventions. As a local haemostatic, fibrin glue has recognised efficacy but, as a plasma-derived product, it carries the risk of viral infections. We, therefore, compared fibrin glue with an autologous haemostatic, plasma rich in growth factors (PRGF), in a controlled trial.One hundred and twenty patients with different blood disorders were randomised into two cohorts to undergo dental extraction procedures without hospitalisation. Prior to the extractions, patients underwent systemic haematological treatment. Complications were defined as secondary bleeding after the 7-day follow-up period or protracting after the repair procedure.There were 106 extractions (7 retained 3(rd) molars) in the group managed with fibrin glue: secondary bleeding affected 3/60 patients (5%) on the third day after extraction and necessitated additional surgery and systemic treatment (in one case the procedure had to be repeated on the 7(th) day). In the PRGF arm there were 98 extractions (23 retained 3(rd) molars): secondary bleeding affected two patients (3.3%) on the first day after extraction and was arrested with surgery without systemic treatment. Four out of the five secondary bleeds occurred in patients with haemophilia A. Concomitant diabetes or liver disease significantly increased the bleeding risk.The bleeding rates in the study and control arm prove that PRGF works as well as fibrin glue as a local haemostatic. Further assets are that PRGF has autologous origin, does not require additional systemic treatment in post-extraction repair surgery, is associated with an earlier onset of neo-angiogenesis and, overall, can reduce patients' distress and costs to the health system.
- Open Access
- 15 April 2012
- Published by Zeus Publishing in International Dental Research
- Vol. 2 (2) , 33-36
Oral Surgery In Severe Thrombocytopaenia Patients: A Case-Control Comparison of Platelet Concentrate Versus Platelet Transfusion
Aim: Surgical treatment of patients with severe thrombocytopaenia (<50,000 platelets/mL) is a major problem for dentists due to an increased risk of bleeding. To reduce post-extraction haemorrhage, we tested a new approach using a platelet concentrate and compared its outcomes with those of routine platelet transfusion. Methodology: Sixty-six patients with a platelet count between 29,000 and 46,000/mL were included in the study. Each patient was to undergo at least two sessions for the extraction of teeth; in one session the patients received a platelet transfusion before the extraction and in the other the post-alveolar sockets were treated with Plasma Rich in Growth Factors (PRGF). Patients were evaluated after 0.4, 1, 3 and 7 days to assess bleeding and haematoma. Results: Patients treated with PRGF consistently exhibited a statistically significant reduction in post-extraction bleeding, hematoma and need for re-intervention. There is ample evidence that application of PRGF in the post-alveolar socket markedly reduced the risk of haemorrhage and associated complications in all patients. Conclusion: PRGF concentrate is recommended for the treatment of thrombocytopaenic patients due to its remarkable ability to stimulate healing while greatly reducing side effects, such as bleeding and haematoma. How to cite this article: Cocero N, Bergamasco L, Mozzati M. Oral Surgery In Severe Thrombocytopaenia Patients: A Case-Control Comparison of Platelet Concentrate Versus Platelet Transfusion. Int Dent Res 2012;2:33-36. Linguistic Revision: The English in this manuscript has been checked by at least two professional editors, both native speakers of English.
- 15 April 2012
- Published by Zeus Publishing in International Dental Research
- Vol. 2 (2) , 33-36
Open AccessOral Surgery In Severe Thrombocytopaenia Patients: A Case-Control Comparison of Platelet Concentrate Versus Platelet Transfusion
Aim: Surgical treatment of patients with severe thrombocytopaenia (<50,000 platelets/mL) is a major problem for dentists due to an increased risk of bleeding. To reduce post-extraction haemorrhage, we tested a new approach using a platelet concentrate and compared its outcomes with those of routine platelet transfusion. Methodology: Sixty-six patients with a platelet count between 29,000 and 46,000/mL were included in the study. Each patient was to undergo at least two sessions for the extraction of teeth; in one session the patients received a platelet transfusion before the extraction and in the other the post-alveolar sockets were treated with Plasma Rich in Growth Factors (PRGF). Patients were evaluated after 0.4, 1, 3 and 7 days to assess bleeding and haematoma. Results: Patients treated with PRGF consistently exhibited a statistically significant reduction in post-extraction bleeding, hematoma and need for re-intervention. There is ample evidence that application of PRGF in the post-alveolar socket markedly reduced the risk of haemorrhage and associated complications in all patients. Conclusion: PRGF concentrate is recommended for the treatment of thrombocytopaenic patients due to its remarkable ability to stimulate healing while greatly reducing side effects, such as bleeding and haematoma. How to cite this article: Cocero N, Bergamasco L, Mozzati M. Oral Surgery In Severe Thrombocytopaenia Patients: A Case-Control Comparison of Platelet Concentrate Versus Platelet Transfusion. Int Dent Res 2012;2:33-36. Linguistic Revision: The English in this manuscript has been checked by at least two professional editors, both native speakers of English.